Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.08M Sell
13,739
-143,380
-91% -$17.4M 0.02% 611
2025
Q4
$17.2M Buy
157,119
+21,680
+16% +$3.15M 0.16% 117
2025
Q3
$19.2M Sell
135,439
-17,116
-11% -$2.49M 0.18% 112
2025
Q2
$24.7M Sell
152,555
-83,757
-35% -$10.4M 0.28% 86
2025
Q1
$25.2M Buy
236,312
+110,290
+88% +$15.4M 0.37% 58
2024
Q4
$15.5M Buy
126,022
+70,782
+128% +$9.98M 0.27% 80
2024
Q3
$7.9M Buy
55,240
+42,225
+324% +$6M 0.2% 98
2024
Q2
$2.13M Buy
13,015
+5,316
+69% +$661K 0.06% 350
2024
Q1
$962K Buy
7,699
+4,477
+139% +$474K 0.02% 581
2023
Q4
$242K Buy
+3,222
New +$188K 0.01% 1122

Other funds holding ARM

Vident Advisory's ARM Position: Q1 2026 in Review

Vident Advisory reduced its Arm (ARM) stake by 91% in Q1 2026, selling an estimated $17.4M and leaving 13,739 shares worth $2.08M. The position accounts for 0.02% of the portfolio, ranked #611.

Vident Advisory first reported a position in ARM in Q4 2023 and has held it in 10 quarters since. The position peaked at $25.2M in Q1 2025. 742 funds tracked by Wall St. Rank hold ARM as of Q1 2026.

  • Vident Advisory held 13,739 shares of Arm worth $2.08M as of Q1 2026.
  • Vident Advisory sold 143,380 Arm shares in Q1 2026, an estimated $17.4M.
  • Arm made up 0.02% of Vident Advisory's portfolio in Q1 2026, its #611 holding.
  • Vident Advisory first reported a position in Arm in Q4 2023 and has held it in 10 quarters since.
  • Vident Advisory's Arm position peaked at $25.2M in Q1 2025.
  • 742 funds tracked by Wall St. Rank held Arm as of Q1 2026.

Based on Vident Advisory's 13F filing for Q1 2026, filed 15 May 2026.